Dermatology
Advertisement
Acupuncture therapy as an adjunct to omalizumab was found to improve disease control and quality of life.
Patient advocate and influencer Alisha Bridges talks about living with Plaque & Scalp Psoriasis as a person of color.
Patients with CSU who utilized a digital telehealth platform reported improved quality-of-life scores.
Dr. Amy McMichael discusses plaque psoriasis on skin of color and Johnson & Johnson's VISIBLE study.
Urticaria raises the risk of ADHD, bipolar disorder, and schizophrenia.
Dupilumab is a monoclonal antibody approved to treat atopic dermatitis in adolescents and children.
Omalizumab is a safe and effective long-term treatment for CSU.
Most respondents agreed a patient-centered definition would improve communication with providers.
Nearly 50% of patients with chronic spontaneous urticaria are atopic, with atopy linked to increased risk of dermatographism,
A recent study demonstrated significant associations between acute urticaria and cardiovascular comorbidities.
Autoimmune mast cell activation test shows promise as a diagnostic tool for chronic spontaneous urticaria.
The global prevalence of pediatric atopic dermatitis increased from 1990 to 2019.
Omalizumab treatment in CSU patients leads to significant changes in T-cell subpopulations.
Patients with both asthma and chronic urticaria have more severe allergic responses.
Omalizumab effectively reduces symptoms in CSU patients, but a 300 mg dose is recommended.
A systematic review found that biologic omalizumab is cost-effective for treating H1 antihistamine–refractory CSU.
survival odds are worse in people with darker skin tones.
Psoriasis was linked to greater odds of asthma and eczema.
According to a recent study, serum zonulin levels had a significant correlation with the urticaria activity score
veterans were more likely to be diagnosed with melanoma at an advanced stage
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.